PETACH TIKVA, Israel,
July 11, 2019 /PRNewswire/ -- OrSense
Ltd., a leading developer of systems for non-invasive measurements
of hemoglobin, today announces the selection of its NBM-200
non-invasive Hemoglobin measurement device by the Banc de Sang I
Teixits, the central blood bank of Catalonia.
Banc de Sang was one of the first major blood banks in
Europe to move from capillary to
non-invasive pre-donation hemoglobin testing. It has been running
the NBM-200 for over five years, conducting nearly 2 million
tests during the period. The new contract is for two years,
with three one-year extension options, for a total of five years.
The NBM-200 uses OrSense's proprietary Occlusion Spectroscopy
technology to replace traditional invasive blood testing, offering
accurate, painless, hemoglobin measurements on location. The
non-invasive test further reduces infection risk, as no blood is
drawn, and with no consumables, such as lancets, gloves etc. and no
need for hazardous waste handling, the system is also
environmentally friendly.
The NBM-200 was recently cleared by the FDA's CBER division
for use in U.S. blood donation centers.
"We are very happy with the Banc de Sang's decision to select
the NBM-200 again," said Yoav
Reisman, CEO of OrSense. "The finger stick is often
mentioned by donors as the most painful part of the blood donation
process. The NBM200's hemoglobin measurement is painless and
represents a win/win for blood donors and blood bank organizations;
it makes the blood donor experience more comfortable and provides
for more efficient, lower cost operations for blood collection
centers."
About OrSense
OrSense is a medical device company developing and marketing
non-invasive hemoglobin, pulse, and oximetry measurement systems
based on its proprietary Occlusion Spectroscopy technology.
OrSense's systems have been successfully installed in dozens of
blood donation and plasma collection facilities worldwide. More
recently, OrSense has begun offering the NBM200 to other
professional healthcare market segments, including selected
physician clinics and anemia screening locations. For additional
information, please visit OrSense's website at
www.orsense.com
About The Banc De Sang I Teixits
The Banc de Sang
i Teixits (Blood and Tissue Bank, BST) is a public agency of
the Catalan Department of Health whose mission is to
guarantee the supply and proper use of human blood and tissue in
Catalonia. It is also a leading center in the field of
immunodiagnostics and advanced therapy development.
OrSense Ltd. contact:
Guy Greitser
OrSense Ltd.
Tel: +972-3-7404911
Email: guy.greitser@orsense.com
Related Images
image1.png
View original content to download
multimedia:http://www.prnewswire.com/news-releases/orsense-nbm-200-non-invasive-hemoglobin-device-selected-by-the-central-blood-bank-of-catalonia-300883949.html
SOURCE OrSense Ltd.